CAPA Assessment Report – High-Level Review of FDA 483 Observations
Introduction This report presents a high-level assessment of the Form FDA 483 issued to Sun Pharmaceutical Industries Ltd., Halol, dated June 13, 2025, following a comprehensive inspection by the United States Food and Drug Administration (USFDA). The inspection revealed eight major observations related to deficiencies in aseptic practices, process validation, equipment maintenance, data integrity, and […]